Lantheus Announces Presentations Featuring PYLARIFY (Piflufolastat F 18) Data at the ASCO GU Meeting
PYLARIFY ® (piflufolastat F 18) Injection is a radioactive diagnostic agent indicated or positron emission tomography (PET) of prostate-specific membrane antigen (PSMA) positive lesions in men with ...
Installed this past fall and used by its first patient in December 2024, the Sanford Joe Lueken Cancer Center boasts a new ...
WVU Medicine St. Joseph’s Hospital is proud to announce the addition of two cutting-edge imaging services: PET/CT and ...
New research results now published from Lund University's MASAI trial are even better than the initial findings from last ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results